JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 23, 2005; DOI: 10.1124/jpet.105.092486


0022-3565/06/3161-271-278$20.00
JPET 316:271-278, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.092486v1
316/1/271    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.-H.
Right arrow Articles by Lee, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.-H.
Right arrow Articles by Lee, J. J.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Blockade of Nuclear Factor-{kappa}B Signaling Pathway and Anti-Inflammatory Activity of Cardamomin, a Chalcone Analog from Alpinia conchigera

Jeong-Hyung Lee, Haeng Sun Jung, Phan Minh Giang, Xuejun Jin, Sangku Lee, Phan Tong Son, Dongho Lee, Young-Soo Hong, Kyeong Lee, and Jung Joon Lee

Anticancer Research Laboratory (J.-H.L., H.S.J., X.J., D.L., Y.-S.H., K.L., J.J.L.) and Laboratory of Immune Modulator (S.L.), Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea; and Faculty of Chemistry, Vietnam National University, Hanoi, Vietnam (P.M.G., P.T.S.)

Nuclear factor-{kappa}B (NF-{kappa}B) and the signaling pathways that regulate its activity have become a focal point for intense drug discovery and development efforts. NF-{kappa}B regulates the transcription of a large number of genes, particularly those involved in immune, inflammatory, and antiapoptotic responses. In our search for NF-{kappa}B inhibitors from natural resources, we identified cardamomin, 2',4'-dihydroxy-6'-methoxychalcone, as an inhibitor of NF-{kappa}B activation from Alpinia conchigera Griff (Zingiberaceae). In present study, we demonstrated the effect of cardamomin on NF-{kappa}B activation in lipopolysaccharide (LPS)-stimulated RAW264.7 cells and LPS-induced mortality. This compound significantly inhibited the induced expression of NF-{kappa}B reporter gene by LPS or tumor necrosis factor (TNF)-{alpha} in a dose-dependent manner. LPS-induced production of TNF-{alpha} and NO as well as expression of inducible nitric-oxide synthase and cyclooxygenase-2 was significantly suppressed by the treatment of cardamomin in RAW264.7 cells. Also, cardamomin inhibited not only LPS-induced degradation and phosphorylation of inhibitor {kappa}B{alpha} (I{kappa}B{alpha}) but also activation of inhibitor {kappa}B (I{kappa}B) kinases and nuclear translocation of NF-{kappa}B. Further analyses revealed that cardamomin did not directly inhibit I{kappa}B kinases, but it significantly suppressed LPS-induced activation of Akt. Moreover, cardamomin suppressed transcriptional activity and phosphorylation of Ser536 of RelA/p65 subunit of NF-{kappa}B. However, this compound did not inhibit LPS-induced activation of extracellular signal-regulated kinase and stress-activated protein kinase/c-Jun NH2-terminal kinase, but significantly impaired activation of p38 mitogen-activated protein kinase. We also demonstrated that pretreatment of cardamomin rescued C57BL/6 mice from LPS-induced mortality in conjunction with decreased serum level of TNF-{alpha}. Together, cardamomin could be valuable candidate for the intervention of NF-{kappa}B-dependent pathological condition such as inflammation.


Received July 11, 2005; accepted September 21, 2005.

Address correspondence to: Dr. Jung Joon Lee, Anticancer Research Laboratory, Korea Research Institute of Bioscience and Biotechnology, P.O. Box 115, Yuseong, Daejeon 305-600, Korea. E-mail: jjlee{at}kribb.re.kr




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H.-M. Kwon, Y.-J. Choi, J.-S. Choi, S.-W. Kang, J.-Y. Bae, I.-J. Kang, J.-G. Jun, S.-S. Lee, S. S. Lim, and Y.-H. Kang
Blockade of Cytokine-Induced Endothelial Cell Adhesion Molecule Expression by Licorice Isoliquiritigenin Through NF-{kappa}B Signal Disruption
Experimental Biology and Medicine, February 1, 2007; 232(2): 235 - 245.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.